Scheduled presentations:

• Keynote Foundational advancement toward development and deployment of digital twins for neoadjuvant therapy of triple negative breast cancer
  *C. Wu (UT MD Anderson Cancer Center), E. Lima (University of Texas at Austin), C. Stowers (University of Texas at Austin), Z. Xu (University of Texas MD Anderson Cancer Center), C. Yam (University of Texas MD Anderson Cancer Center), J. Son (University of Texas MD Anderson Cancer Center), J. Ma (University of Texas MD Anderson Cancer Center), G. Rauch (University of Texas MD Anderson Cancer Center), T. Yankeelov (University of Texas MD Anderson Cancer Center)
• Digital Twins in Computational Oncology: Probabilistic Formulation of Personalized Risk Assessment
  *F. Arceci (Politecnico di Milano), P. Vitullo (Politecnico di Milano), B. Dionisi Ferrara (Istituto Nazionale dei Tumori), M. Tezzele (Emory University), P. Zunino (Politecnico di Milano), T. Rancati (Istituto Nazionale dei Tumori)
• Utilizing Histopathology to Calibrate Digital Twins of Tumors
  *P. Schlicke (University of Salzburg), N. Fortelny (University of Salzburg), H. Enderling (MD Anderson Cancer Center)
• Digital-twin framework to investigate the impact of vertebral metastatic lesions on spinal biomechanics.
  *S. Laranjeira (UCL), S. Walker-Samuel (UCL), R. Shipley (UCL)
• TMEImmune and Beyond: Patient-Specific Computational Models for Precision Cancer Treatment
  *L. Shahriyari (University of Massachusetts Amherst)